16
Participants
Start Date
January 31, 2009
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2011
sunitinib, docetaxel, cisplatin
"1. Sunitinib given 10 days within 14 days of each cycle。~2. Sunitinib 25 mg/day with adjust dosage according to patient's condition, but should return to 25 mg when feasible or should withdraw from this study.~3. Docetaxel 40-50 mg/m2, cisplatin 50 mg/m2 every 2 weeks.~4. Overall 12 cycles (24 weeks)"
RECRUITING
Section of Hematology, Department of Medicine,Taipei Medical University Hospital, Taipei
Collaborators (1)
Pfizer
INDUSTRY
TTY Biopharm
INDUSTRY
Taipei Medical University Hospital
OTHER